Matias B. de Tullio

The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.

A. Roher, L. Morelli, M. Leissring, 2008, The Journal of biological chemistry.

The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme

L. Morelli, E. Castaño, Matias B. de Tullio, 2008, Prion.

A β‐amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid β‐peptide

I. Hamley, V. Castelletto, E. Castaño, 2010, Journal of peptide science : an official publication of the European Peptide Society.

Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic Aβ Peptide Aggregates

I. Hamley, L. Morelli, V. Castelletto, 2013, PloS one.

The Catalytic Domain of Insulin-degrading Enzyme Forms a Denaturant-resistant Complex with Amyloid β Peptide

A. Roher, L. Morelli, M. Leissring, 2008, Journal of Biological Chemistry.